IHS Chemical Week

People & Business :: Companies

AMRI to Get BMS Milestone Payment

1:44 PM MDT | July 30, 2007 | Chemical Week Editorial Staff

Albany Molecular Research Inc. (AMRI; Albany, NY) says it will receive a payment of $1.5 million from Bristol-Myers Squibb (BMS) for a chemical compound it developed under license agreement with the pharma company. This is the first milestone in the ongoing research collaboration between the two companies to develop treatments for depression and diseases of the central nervous...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa